Beste Pharmaphorum podcaster (2024)

1
CAR-T therapies: Faster, better, cheaper 17:56

4d ago17:56

17:56

In a new pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Phil Johnson, MD, president and CEO of Interius Biotherapeutics. Working in the in vivo cell therapy space, Johnson discusses the injection of a manufactured vector into a patient to create the CAR-T cells directly inside the body of the patient, without the need for chemothe…

1
Looking to history to prepare for America’s uncertain future 18:21

11d ago18:21

18:21

Since the results of the US election, the news has been awash with what the future might hold under a second Trump Administration, particularly within healthcare and life sciences. In today’s podcast, web editor Nicole Raleigh is joined by Jesse Mendelsohn, senior vice president of Model N’s Center of Excellence, for a conversation that explores mu…

1
Next gen wearables: Transforming remote patient care 18:38

18d ago18:38

18:38

Virtual wards (also known as hospital at home) allow patients to get the care they need at home safely and conveniently, rather than being in hospital. The NHS is increasingly introducing virtual wards to support people at the place they call home, including care homes. In today’s podcast, web editor Nicole Raleigh speaks with Dr Samuel Ewing, glob…

1
From neurosurgery to focused ultrasound: Not if, but when 16:14

25d ago16:14

16:14

Therapeutic or focused ultrasound began being applied to neurologic conditions less than a decade ago, but its potential in a wide spectrum of brain applications is high. In today’s podcast, web editor Nicole Raleigh speaks with Dr Neal Kassell, chair and founder of the Focused Ultrasound Foundation and previously a neurosurgeon, who created the Fo…

1
A journey from personal to public: Digital health passports today 34:18

1M ago34:18

34:18

A digital health passport is an app, or online certification, that displays a traveller’s health or vaccination record. It can save lives, on both private and public levels. In today’s pharmaphorum podcast, web editor Nicole Raleigh speaks with Matt Hollingsworth, co-founder and CEO of Carta Healthcare, a company seeking to support the healthcare d…

1
Access to genomic surveillance: Open science and public health 18:28

1M ago18:28

18:28

The pandemic served as a catalyst for a revolution in genomic surveillance for tracking pathogens. The technology proved vital in aiding understanding of the evolution of and spread of virus in real time to inform public health measures, ultimately accelerating drug and vaccine development. In today’s podcast, web editor Nicole Raleigh speaks with …

1
Advancing Precision Care For All 27:42

2M ago27:42

27:42

Precision medicine is oft spoken about these days, as it is finally addressing the elephant in the room: one size – or, more appropriately, one dose – does not fit all. Precision medicine hones in on treatment of the individual, rather than just the disease, focusing on the reality that each patient is biologically different. Personalisation is ver…

1
Investment outlook: Key takeaways from LSX USA 33:16

2M ago33:16

33:16

Investment and strategic partnerships are the lifeblood of innovation in healthcare, driving groundbreaking discoveries and accelerating the development of life-changing therapies. And so, it was no surprise that the 2024 LSX USA Congress in Boston attracted life sciences innovators and decision-makers from around the world, eager to explore the la…

1
Oncology today: Eversana and pharmaphorum at ESMO 2024 18:44

2M ago18:44

18:44

The ESMO congress always disseminates the latest results of cancer research, a vibrant gathering and sharing of the latest data, communicating the next promising steps in oncological scientific development, ever seeking to address unmet patient needs. So it was that pharmaphorum Web Editor Nicole Raleigh found a quiet spot onsite in Barcelona this …

1
Medicare drug pricing negotiations: What comes next? 28:32

3M ago28:32

28:32

Last month, the US Centers for Medicare and Medicaid Services released the negotiated prices for the first 10 drugs subject to the drug negotiation provisions in the Inflation Reduction Act. The industry has been waiting with bated breath to see these prices, as they give the first real indication of how impactful this unprecedented legislation wil…

1
The Life Sciences Generative AI Council and a sustainable technological future 17:06

3M ago17:06

17:06

The Life Sciences Generative AI Council aims to bring together the best minds in pharma, academia, and technology to advance the use of GenAI in life sciences R&D, seeking through pinpointing and showcasing repeatable use cases to shape the targeted use of next-generation artificial intelligence and machine learning (AI-ML) innovation, particularly…

1
Can self-navigating ADCs replace chemotherapy in the future? 19:43

3M ago19:43

19:43

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Brian Fiske, chief scientific officer of Mythic Therapeutics, about minimising side effects for patients and the notion of patient-centred science.Av pharmaphorum

1
Structuring the unstructured: Deterministic AI and white box data cleanliness 18:31

3M ago18:31

18:31

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Jane Reed, director of life sciences at Linguamatics, an IQVIA company, to discuss some of the major barriers preventing researchers from accessing the data they need to advance drug discovery and development and address safety concerns – and just how AI technologies can assist.…

1
People need to know how to use AI now 31:19

4M ago31:19

31:19

With the implementation of advancing technologies in industry comes the parallel need for suitable upskilling of the workforce – but this doesn’t as yet always pan out, and in today’s pharmaphorum podcast COO of Enthought Mike Connell discusses the growing skills gap in R&D in life sciences and the 80/20 rule with web editor Nicole Raleigh, as well…

1
Chronic cough and the patient voice 14:09

4M ago14:09

14:09

Chronic cough impacts up to 10% of the adult population and has a physical, psychological, and social impact on patients’ lives. Farrell Simon, chief commercial officer at Trevi Therapeutics, joins web editor Nicole Raleigh on the pharmaphorum podcast to discuss prioritising patients in clinical and commercial development, with an especial focus on…

1
Approaching the regulatory world with passion: CERs and EU MDR processes 21:46

4M ago21:46

21:46

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Ethan Drower, co-founder and CEO of Cite Medical Solutions, a company providing full Clinical Evaluation Report (CER) services and industry literature review for European Union Medical Device Regulation (or EU MDR) processes.Av pharmaphorum

1
Patient engagement throughout the product lifecycle 28:34

4M ago28:34

28:34

One of the things that makes patient engagement for pharma companies so challenging is that it's not something that can be added to one step of a process and then checked off the list. Real patient engagement needs to be integrated into processes every step of the way. In today's podcast, brought to you by Reverba, Reverba CEO Cheryl Lubbert joins …

1
The empowerment of data and predictive outcome models 21:32

4M ago21:32

21:32

In today’s podcast, web editor Nicole Raleigh speaks with Carolyn Ward, director of clinical strategy at Particle Health Inc, a data transformation platform for healthcare, enabling organisations across the care continuum to turn medical records into actionable insights.Av pharmaphorum

1
The burden of diabetic vision loss in the West 17:24

5M ago17:24

17:24

In today’s podcast, web editor Nicole Raleigh welcomes Dr Catherine Beech, CEO of Exonate, for a discussion on retinal vascular disease and a potential eye drop treatment for diabetic retinopathy and diabetic macular oedema, instead of invasive injections into the eye.Av pharmaphorum

1
Tips for on-time tech transfers that stay below budget 25:09

5M ago25:09

25:09

When it comes to life sciences manufacturing, there's nothing quite so daunting as a tech transfer - moving a product from development to commercialisation, or to a new facility or CDMO, presents many obstacles that have to be well thought out and planned. Delivering a tech transfer on schedule that stays below budget is no easy feat, but with the …

1
Clinical trial trends and the rise of site networks 29:28

5M ago29:28

29:28

We've recently passed the midpoint of 2024, so it's a good time to check in on trends – in this case, trends in the clinical trial space. In today's podcast, brought to you by Advanced Clinical, host Jonah Comstock is joined by Jason Casarella, EVP of business development and marketing at Advanced Clinical and Caroline Redecker, chief strategy offi…

1
A spectrum of obesity requires precision 23:47

5M ago23:47

23:47

In this latest pharmaphorum podcast, web editor Nicole Raleigh speaks with Michael Kyle, chief medical officer at Currax Pharmaceuticals – a company working to advance a greater understanding of how to effectively treat obesity – about perceptions and options beyond the bounds of GLP-1s, including evolution of hypertension treatments.…

1
The power and potential of regenerative medicine 20:02

5M ago20:02

20:02

The field of muscle stem cell research has been tangibly developing over the decades and in today’s pharmaphorum podcast wed editor Nicole Raleigh speaks with Dr Michael Rudnicki, co-founder and CSO of Satellos Biosciences, a company dedicated to developing novel therapeutics based on this science for those who live with Duchenne muscular dystrophy…

1
Leveraging data and AI for clinical trial success 15:25

5M ago15:25

15:25

In today’s pharmaphorum podcast, Orr Inbar, co-founder and CEO of QuantHealth, a Tel Aviv-based AI-powered clinical trial design company, discusses how advances in data and AI can help.Av pharmaphorum

1
The future of fertility and the vaginal microbiome 24:54

5M ago24:54

24:54

In a new episode of the pharmaphorum podcast - recorded back in March, during Women’s History Month - web editor Nicole Raleigh spoke with Johan van Hylckama Vlieg, co-founder and chief scientific officer of Freya Biosciences, a Series A-financed, clinical stage, microbial immunotherapy company in women’s health, discussing the role of the vaginal …

1
Sustainable innovation for patients, people, and planet 29:13

5M ago29:13

29:13

Sustainability is all important for the planet and its people, and in today’s podcast web editor Nicole Raleigh speaks with Harriet Lewis, director of public affairs and communications at Chiesi UK & Ireland, about how partnerships between the NHS and pharma industry can support the journey to more sustainable practices, from R&D and drug reimburse…

1
The new frontier of microbiome-directed human health 30:47

5M ago30:47

30:47

The microbiome is ever more frequently spoken about of late, and so the pharmaphorum podcast invited Leo Grady, founder and CEO of Jona, to speak about at-home personal microbiome profiling, uncovering the relationship between human health and the gut.Av pharmaphorum

1
Global medicines and the future outlook 28:39

6M ago28:39

28:39

In a conversation held earlier in the year as the four-year anniversary of the pandemic approached, the pharmaphorum podcast had as guest Murray Aitken, executive director of the IQVIA Institute for Human Data Science, to discuss the state of global medicines and the future outlook when it comes to research and development, and usage and spending a…

1
Purity, potency, and safety – affordably – in stem cell therapy 28:25

6M ago28:25

28:25

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh discusses stem cell therapy, and accessibility to and affordability of such treatment, with Rafael R Carazo Salas, founder and CEO of CellVoyant, an AI-first biotechnology company spun out from the University of Bristol.Av pharmaphorum

1
The art of software 27:12

6M ago27:12

27:12

In this episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Rob Pears, VP and head of automotive, manufacturing, and life sciences at Capgemini, which partners with companies to transform and manage their business by harnessing the power of technology.Av pharmaphorum

1
Move over CAR-T: The potential of NK cells in cell therapy 34:31

6M ago34:31

34:31

On today’s podcast, Dr. Fred Aslan, CEO of Artiva Biosciences, joins host Jonah Comstock to talk more about this newer avenue in cell therapy. They discuss the potential of NK cells to provide effective allogeneic cell therapy, the potential of the therapy in auto-immune disease, and the importance of a robust manufacturing process that can get a h…

1
Working for a mature form of genomic medicines 20:08

6M ago20:08

20:08

In a new episode of the pharmaphorum podcast, Rahul Kakkar, CEO of gene editing company Tome, speaks with web editor Nicole Raleigh about programmable genomic integration (PGI) technology.Av pharmaphorum

1
Challenges and opportunities in synthetic clinical trials 44:01

6M ago44:01

44:01

On today’s episode Web Sun, president and cofounder of Komodo Health and Tracy Mayne, SVP regulatory and life sciences research at Slipstream IT, talk about this trend, where the industry is now, and what they’re doing to move it along.Av pharmaphorum

1
The commercialisation of quantum science in pharma 26:03

6M ago26:03

26:03

In today’s podcast, web editor Nicole Raleigh speaks with PASQAL’S technical business developer Europe, Krisztian Benyo, PhD, about the pharma applications and commercialisation of quantum science.Av pharmaphorum

1
Conference report: Reuters Pharma Europe 37:25

7M ago37:25

37:25

In this special edition of the pharmaphorum podcast, the tables have turned as Jonah Comstock puts editors Eloise McLennan and Nicole Raleigh in the hot seat to discuss the biggest trends and talking points from last month’s Reuters Pharma Europe 2024 in Barcelona.Av pharmaphorum

1
In vitro gametogenesis: the science has to be right, and it has to be safe 16:46

7M ago16:46

16:46

Today’s podcast sees web editor Nicole Raleigh speak with Dr Mark Leondires, founder and medical director at Illume Fertility, who shares his own journey and insights on In vitro gametogenesis (IVG).Av pharmaphorum

1
Proving ROI for digital endpoints 32:58

7M ago32:58

32:58

Jennifer Goldsack of DiME talks in this podcast about the ROI for digital endpoints for pharma. Data shows digital endpoints drives meaningful engagement with healthcare providers.Av pharmaphorum

1
Clinical trials: their design, location, and, potentially, their simulation 17:09

7M ago17:09

17:09

Clinical trials, their design and location, and these days their simulation, are the focus of today’s podcast with Dr Gen Li, founder and president of Phesi.Av pharmaphorum

1
Pace, acceleration, and precision are the name of the game 20:34

7M ago20:34

20:34

Security and privacy within biotech are critical points of consideration and discussion as the industry continues to innovate at speed, and it is such aspects that are central to today’s podcast with Zach Powers, chief information security officer at Benchling, the R&D cloud platform for the biotech industry.…

1
Technology working as the puzzle piece to bring better outcomes to patients 18:28

7M ago18:28

18:28

While at Reuters Pharma Europe in Barcelona the other week, pharmaphorum web editor Nicole Raleigh spoke with Florian Schnappauf, VP of enterprise commercial strategy at Veeva Europe, about commercial strategy and digitalising commercial operations.Av pharmaphorum

1
Is precision psychiatry possible? 35:38

7M ago35:38

35:38

On today’s podcast, host Jonah Comstock is joined by Dr Amit Etkin, founder and CEO of Alto Neuroscience, a recently IPO'd biotech that wants to bring precision medicine to psychiatry. But what do we mean when we talk about precision, especially in a discipline like mental health that has historically involved a lot of objectivity?…

1
Encouraging early engagement to revitalise Europe’s pharmaceutical landscape 19:31

7M ago19:31

19:31

In an on-site interview at Reuters Pharma Europe in Barcelona, this week’s podcast saw Tommy Bramley, SVP of market access and healthcare consulting at Cencora, discuss revitalising Europe’s pharmaceutical landscape and leveraging legislation for health and competitiveness.Av pharmaphorum

1
Predictions for AI in mental health in the coming year 22:35

8M ago22:35

22:35

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh welcomes Dr Carl Marci, chief psychiatrist and managing director of mental health and neuroscience at OM1 to discuss predictions for AI in mental health in the coming year, as well as what might truly make a difference in the field and lessen the mental health crisis.…

1
Fixing clinical trial data management 26:34

8M ago26:34

26:34

It’s 2024 and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another. How did we get here? And how do we get past it? On today’s pharmaphorum podcast, host Jonah Comstock speaks with Iddo Peleg, CEO of Yonalink, about these very questions.…

1
Harnessing the velocity of biopharmaceutical advances 18:10

8M ago18:10

18:10

On today's episode of the podcast CEO and co-founder of 908 Devices Kevin Knopp joins as guest, discussing how such acceleration is by virtue of technological advancements, including the buzzword artificial intelligence (AI) and machine learning when it comes to bioprocessing.Av pharmaphorum

1
Conference report: Reuters Pharma USA 38:02

8M ago38:02

38:02

Last week, pharmaphorum Editor in Chief Jonah Comstock traveled to Philadelphia for Reuters Pharma USA. On today’s podcast, he chats with guest host and Deep Dive Editor Eloise McLellan about his biggest takeaways from the two-day event.Av pharmaphorum

1
The future of AI: Machine learning working together with scientific expertise 10:28

8M ago10:28

10:28

In a new episode of the pharmaphorum podcast recorded live on site at WIRED Health in London in March, web editor Nicole Raleigh spoke with Elise de Reus, co-founder of Cradle, the generative AI platform that helps scientists to design and program proteins.Av pharmaphorum

1
Understanding the politics of drug pricing in the United States 35:53

8M ago35:53

35:53

Everyone says they want more affordable drugs for patients that need them, but people disagree quite a bit on who's to blame for the current status quo of sky-high prescription prices – not to mention how they might be corrected. To help unpack some of those trends and conflicting perspectives, Brandon Newman, CEO of healthcare analytics firm Xevan…

1
Female leadership and lessening disease burden 14:59

8M ago14:59

14:59

As Women’s History Month comes to its final week, today’s podcast sees web editor Nicole Raleigh in conversation with Debra Weiss, COO of the Bill & Melinda Gates Medical Research Institute (Gates MRI), discussing her role as a female leader in the leader and the non-profit organisation’s work in developing novel biomedical interventions and lessen…

1
The unique clinical trial challenges faced by digital therapeutics 27:56

8M ago27:56

27:56

On today’s podcast, host Jonah Comstock is joined by Meri Beckwith, cofounder of Lindus Health, a next-gen CRO that includes digital therapeutics among its specialties. They talk a little bit about often unseen difficulties of validating a digital therapeutic through a clinical trial.Av pharmaphorum

Podcaster verdt å lytte til

Pharmaphorum Podcaster

Podcaster verdt å lytte til

Hurtigreferanseguide